as 12-20-2024 4:00pm EST
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
Founded: | N/A | Country: | China |
Employees: | N/A | City: | HAINAN PROVINCE |
Market Cap: | 4.2M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 379.7K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.35 | EPS Growth: | N/A |
52 Week Low/High: | $0.13 - $0.70 | Next Earning Date: | 11-13-2024 |
Revenue: | $5,544,620 | Revenue Growth: | -28.76% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
CPHI Breaking Stock News: Dive into CPHI Ticker-Specific Updates for Smart Investing
PR Newswire
5 days ago
PR Newswire
10 days ago
PR Newswire
4 months ago
Newsfile
6 months ago
CNW Group
6 months ago
GlobeNewswire
6 months ago
GlobeNewswire
6 months ago
GlobeNewswire
6 months ago
The information presented on this page, "CPHI China Pharma Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.